Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients
2020 · Transplantation Direct · 52 citations
https://doi.org/10.1097/txd.0000000000000988
H
Haris Murad
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
891
Citations
10
h-index
11
i10-index
Haris Murad is an academic researcher from Aga Khan University. The author has contributed to research in topics: Renal Transplantation Outcomes and Treatments & Organ Donation and Transplantation & Organ Transplantation Techniques and Outcomes. The author has an h-index of 10, co-authored 23 publications.
ORCID: 0000-0002-4902-2732Papers by this author
worksRepeat SARS-CoV-2 testing after recovery. Is a pretransplant PCR necessary?
2021 · American Journal of Transplantation · 12 citations
https://doi.org/10.1111/ajt.16506
Utility of Donor-Derived Cell-Free DNA in Detecting ABMR in Patients With AT1R Antibodies
2021 · Kidney International Reports · 5 citations
https://doi.org/10.1016/j.ekir.2021.07.026
Outcomes Following In-Hospital Cardiopulmonary Resuscitation in People Receiving Maintenance Dialysis
2021 · Kidney Medicine · 4 citations
https://doi.org/10.1016/j.xkme.2021.08.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat